| Product Name |
GBDR1 |
| Antibody Type |
Primary Antibodies |
| Antigen Alias |
UBAC1 antibody; GBDR1 antibody; KPC2 antibody; UBADC1 antibody; Ubiquitin-associated domain-containing protein 1 antibody; UBA domain-containing protein 1 antibody; E3 ubiquitin-protein ligase subunit KPC2 antibody; Glialblastoma cell differentiation-related protein 1 antibody; Kip1 ubiquitination-promoting com antibody; |
| Product description |
Non-catalytic subunit of the KPC complex that acts as E3 ubiquitin-protein ligase. Required for poly-ubiquitination and proteasome-mediated degradation of CDKN1B during G1 phase of the cell cycle. pathway:Protein modification; protein ubiquitination. Contains 1 STI1 domain. Contains 1 ubiquitin-like domain. Contains 2 UBA domains. subunit:Component of the KPC complex composed of RNF123/KPC1 and UBAC1/KPC2. Interacts with RNF123 via its N-terminal domain. Interacts with the proteasome via its N-terminal domain. tissue specificity:Ubiquitous. |
| Immunogen |
The antiserum was produced against synthesized peptide derived from human UBAC1. AA range:91-140 |